elara capital people page on Anadi Algo News

Monday, June 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
People Landing|80 matching stories

elara capital News, Mentions & Market Context

AI-analyzed market coverage and mentions for elara capital, including related stories and trading context.

What Traders Do Next

elara capital is more useful with a process around it.

Use these pages to understand the story first. Execution usually comes later, after the idea is filtered, tested, and sized correctly.

This is here if you want to go deeper, not as a push.Explore Anadi
Maintain a bullish bias on railway infrastructure stocks; look for entry points on minor corrections, with a stop-loss below recent support levels.

Latest elara capital Mentions

Traders should prepare for potentially higher liquidity and increased trading opportunities in the final 10 minutes of F&O trading; consider adjusting stop-loss and target levels for intraday derivative positions.
Maintain a bullish bias on fundamentally strong pharma stocks with clear product pipelines and positive regulatory outlooks, with strict stop-losses.
Maintain a bullish bias on infrastructure and related financial stocks, focusing on companies with strong balance sheets and proven execution capabilities, with a stop-loss below recent support levels.
Positive bias for premium real estate developers; look for strong sales growth and project launches.
Maintain a cautious but opportunistic approach; look for dips as buying opportunities if the underlying trend remains strong.
Given the regulatory overhang and reputational risk, a bearish bias is warranted for Suzlon Energy (SUZLON) in the near term, with potential for further downside if investor confidence erodes.
Bearish bias for Indian IT stocks, particularly those with high exposure to US tech clients and AI-related services.
Maintain a bullish bias on power and renewable energy stocks, focusing on companies with strong balance sheets and proven execution capabilities in storage projects.
Maintain a bullish bias on Indian EV and battery component manufacturers, looking for entry points on any market corrections, with a focus on companies with established manufacturing capabilities.
Favor long positions in OMCs (IOC, BPCL, HPCL) and aviation stocks (INDIGO) due to reduced input costs, while maintaining a cautious stance on upstream producers (ONGC, OIL) given the negative impact on realizations.
et_markets17 days ago+10

EU's six biggest economies agree on capital markets supervision

5 facts
Maintain a neutral stance on pharma stocks based on this news; focus on sector-specific fundamentals like USFDA approvals and product pipelines.
Maintain a cautious stance on Suzlon Energy (SUZLON) due to regulatory overhang; consider short-term bearish positions or avoiding fresh long entries until clarity emerges.
Given the regulatory action, traders should maintain a bearish bias on Suzlon Energy (SUZLON) in the short term, focusing on downside risk and potential for further negative news.
Maintain a positive bias on well-capitalized Indian banks, focusing on those with strong asset quality and credit growth, but exercise caution with individual stock-specific news.
et_markets17 days ago+40

Sebi eases nomination rules for demat accounts, mutual funds. Check full details

5 facts
Positive bias for capital market intermediaries and AMCs; look for growth in investor participation metrics.
For Rodec Pharma, evaluate the IPO prospectus carefully, focusing on product pipeline, regulatory approvals, and valuation relative to listed peers for potential long-term investment or listing gains.
Maintain a cautious stance on wind energy stocks; look for strong order book visibility and consistent execution before taking long positions.
Adopt a defensive stance with strict stop-losses and consider reducing leverage, focusing on capital preservation during uncertain market conditions.
Maintain a bullish bias on companies providing critical infrastructure for the IT sector, focusing on those with strong order books and execution capabilities. Implement strict risk discipline with stop-losses.
Bullish on Vedanta Ltd (VEDL) due to improved financial standing and potential for lower cost of capital.
Neutral for the broader market; potential long-term negative for real estate stocks, positive for financial platforms facilitating bond investments.
Focus on OMCs (IOC, BPCL, HPCL) for potential long-term infrastructure-driven growth; look for dips to accumulate.
Maintain a bullish bias on NETWEB, looking for consolidation after the sharp rally, with potential entry points on minor pullbacks, while strictly adhering to risk management.|Quick check: NETWEB bullish bias (+0.0% 1d), SUNPHARMA neutral (+0.0% 1d).
Maintain a cautious bias on capital goods stocks with extremely high P/E ratios; prioritize companies with strong order books and reasonable valuations.|Quick check: HITACHIENE neutral, SUNPHARMA neutral (+0.0% 1d).
et_markets17 days ago+7.9

Bitcoin consolidates near $73,600 as whale outflows hit highest level since February

4 facts
N/A - The news is not relevant to the pharma sector.|Quick check: SUNPHARMA neutral (+0.0% 1d), CIPLA neutral (overbought).
For CUMMINSIND, a 'Neutral' rating suggests a hold or profit-booking strategy; consider reducing exposure on rallies, with a focus on managing risk around current valuation levels.|Quick check: CUMMINSIND bullish bias (overbought), MARUTI neutral (+0.0% 1d).
Maintain a bullish bias on banking stocks, focusing on those with strong capital adequacy and diversified loan books, with strict risk management.|Quick check: HDFCBANK neutral (+0.0% 1d), ICICIBANK neutral (+0.0% 1d).
Maintain a long-term bullish bias on Indian IT companies with strong automotive and engineering services capabilities, focusing on those securing new AI-related contracts.|Quick check: TCS bearish bias (+0.0% 1d), WIPRO neutral (+0.0% 1d).
Maintain a selective approach in pharma; focus on companies with strong product pipelines, clear regulatory approvals, and stable domestic demand, with strict risk management.|Quick check: SUNPHARMA neutral (+0.0% 1d), CIPLA neutral (overbought).
Maintain a bullish bias on established Indian pharma and diagnostic stocks, focusing on companies with strong balance sheets and growth prospects, with disciplined risk management.|Quick check: DRL neutral, LUPIN neutral (+0.0% 1d).
Maintain a bearish bias on banking stocks; consider short positions or reducing exposure if credit growth shows signs of unproductivity or if asset quality deteriorates.|Quick check: SBIN neutral (+0.0% 1d), HDFCBANK bearish bias (+0.0% 1d).
Maintain a bearish bias on BDL and other defence PSUs in the short term, with a focus on risk management around potential further declines and sector-wide profit-booking.|Quick check: BDL bearish bias (oversold), GRSE bearish bias (oversold).
Neutral to slightly negative bias for AMARAJABAT due to execution risks in EV. Watch for competitor EXIDEIND's progress.|Quick check: AMARAJABAT neutral, EXIDEIND bullish bias (+0.0% 1d).
Consider long positions in well-capitalized banks and NBFCs with strong retail lending arms, focusing on those actively promoting loans against securities. Maintain strict stop-losses.|Quick check: HDFCBANK bearish bias (+0.0% 1d), ICICIBANK neutral (+0.0% 1d).
Consider long positions in fundamentally strong pharma stocks with clear product pipelines and favorable regulatory outlooks, maintaining strict stop-losses.|Quick check: SUNPHARMA neutral (+0.0% 1d), CIPLA neutral (overbought).
Consider long positions in the identified large-cap stocks with a tight stop-loss below the Marubozu candle's low, targeting near-term resistance levels.|Quick check: TATAMOTORS bullish bias (overbought), NIFTY bearish bias (oversold).
Look for long opportunities in well-capitalized infrastructure and construction companies with a proven track record in highway projects, setting stop-losses below recent support levels.|Quick check: POWERGRID bearish bias (+0.0% 1d), NHAI neutral.
Maintain a bullish bias on railway infrastructure and safety system providers, with HBLPOWER as a direct beneficiary of this specific order.|Quick check: HBLPOWER neutral, MARUTI neutral (+0.0% 1d).
This news has no direct bearing on the Indian pharma sector. Traders should continue to focus on sector-specific news like regulatory approvals, product pipelines, and pricing pressures for pharma stocks.|Quick check: NIFTY bearish bias (oversold), SENSEX neutral.
Consider long positions in well-capitalized real estate developers and housing finance companies, focusing on those with significant exposure to Bengaluru, Mumbai, and Delhi-NCR. Maintain strict stop-losses.|Quick check: LICHSGFIN neutral (+0.0% 1d), NIFTY bearish bias (oversold).
While not a direct pharma catalyst, a favorable tax regime for dividends could make dividend-paying pharma stocks more attractive; maintain a long bias on quality pharma names with strong fundamentals.|Quick check: SUNPHARMA neutral (+0.0% 1d), CIPLA neutral (overbought).
Positive bias for infrastructure and construction stocks; look for companies with strong order books and execution capabilities.|Quick check: IRB neutral (+0.0% 1d), SUNPHARMA neutral (+0.0% 1d).
This news is a strong positive for RELIANCE, suggesting a bullish bias. Traders should look for entry points on any dips, with a focus on long-term growth potential.|Quick check: RELIANCE bearish bias (oversold), HDFCBANK bearish bias (+0.0% 1d).
Maintain a bullish bias on financial intermediaries and platforms that can capitalize on increased debt market activity, with a focus on long-term growth potential.|Quick check: TCS neutral (+0.2% 1d), INFY neutral (-0.4% 1d).
Focus on pharma companies with strong R&D pipelines and clean regulatory records; consider long positions on dips with strict stop-losses.|Quick check: SUNPHARMA neutral (-0.1% 1d), CIPLA neutral (overbought).
Maintain a neutral to slightly bullish bias on select large-cap pharma stocks with strong pipelines and USFDA compliance, with strict risk management.|Quick check: SUNPHARMA neutral (-0.1% 1d), CIPLA neutral (overbought).
Maintain a neutral to slightly positive bias on Indian IT stocks with strong digital and blockchain capabilities, but acknowledge that direct impact from this news is limited and long-term.|Quick check: SUNPHARMA neutral (-0.1% 1d), CIPLA neutral (overbought).
Look for accumulation patterns in these HNI-favored stocks; consider long positions with strict stop-losses below recent support levels.|Quick check: DMART bearish bias (oversold), VEDANTA bullish bias (overbought).
livemint_markets18 days ago+46.1

Vijay Kedia wants LTCG tax on equities abolished — says long-term investors must be rewarded

5 facts
Monitor government policy discussions; any positive indication on LTCG could lead to broad market upside.|Quick check: SUNPHARMA neutral (-0.1% 1d), CIPLA neutral (overbought).
Maintain a bearish bias on auto stocks due to rising input costs and potential demand slowdown from higher fuel prices; consider shorting auto OEMs and ancillaries.|Quick check: ONGC bearish bias (-4.8% 1d), OIL neutral (-0.9% 1d).
Maintain a bullish bias on select mid and smallcap stocks in EMS, Capital Goods, and Auto Ancillaries, while being selective and cautious in traditional IT.|Quick check: NIFTY neutral, TCS neutral (+0.2% 1d).
livemint_companies18 days ago+8.6

EQT appoints Nicholas Macksey and Hari Gopalakrishnan as co-heads of Private Capital Asia

5 facts
No direct trade setup for the pharma sector based on this news. Continue to monitor USFDA/regulatory signals and product pipelines for pharma stocks.|Quick check: SUNPHARMA neutral (-0.1% 1d), CIPLA neutral (overbought).
Bias towards defensive sectors or companies with strong domestic demand and low foreign debt exposure. Consider short-term hedges against potential FII selling pressure.|Quick check: NIFTY neutral, BANKNIFTY bullish bias (+24.6% 1d).
Positive bias for banking stocks with exposure to real estate financing and for real estate developers focused on affordable housing.|Quick check: HDFCBANK bearish bias (-2.6% 1d), DLF neutral (+0.7% 1d).
Neutral for listed stocks, but bullish for the broader startup ecosystem; watch for future IPOs.|Quick check: SUNPHARMA neutral (-0.1% 1d), CIPLA neutral (overbought).
Bias is bullish for real estate and related financial services; look for developers with strong affordable housing pipelines.|Quick check: HDFCBANK bearish bias (-2.6% 1d), DLF neutral (+0.7% 1d).
Neutral for short-term; long-term positive for Indian capital markets as part of broader Asian growth.|Quick check: TATASTEEL bullish bias (+2.0% 1d), HINDALCO bullish bias (overbought).
Maintain a bullish bias on well-capitalized microfinance NBFCs, particularly those demonstrating diversified funding strategies; consider long positions with strict stop-losses.|Quick check: SATIN neutral, HDFCBANK bearish bias (-2.6% 1d).
Maintain a selective long bias in the pharma sector, focusing on companies with strong pipelines, favorable regulatory outcomes, and sound capital allocation strategies like buybacks.|Quick check: ZYDUSLIFE bullish bias (overbought), SUNPHARMA neutral (-0.1% 1d).
Adopt a cautious stance; monitor FII flows and government policy announcements.|Quick check: SUNPHARMA neutral (-0.1% 1d), CIPLA neutral (overbought).
Consider short positions or hedging strategies for banking and NBFC stocks.|Quick check: HDFCBANK bearish bias (-2.6% 1d), ICICIBANK neutral (-0.6% 1d).
Maintain a bullish bias on COALINDIA, focusing on its dividend yield and potential for capital appreciation, with a stop-loss below recent support levels.|Quick check: COALINDIA bullish bias (+1.7% 1d), TATASTEEL bullish bias (+2.0% 1d).
Consider long positions in Hitachi Energy India (POWERINDIA) due to strong growth drivers.|Quick check: POWERINDIA bullish bias (+4.9% 1d), MARUTI neutral (+1.2% 1d).
Consider long positions in JSW Steel (JSWSTEEL) for long-term growth potential.|Quick check: JSWSTEEL bullish bias (+1.3% 1d), TATASTEEL bullish bias (+2.0% 1d).
Maintain a neutral to slightly bullish bias on the broader market, but be prepared to adjust based on specific sector or thematic insights emerging from the summit.|Quick check: SUNPHARMA neutral (-0.1% 1d), CIPLA neutral (overbought).
Maintain a cautious stance on banking stocks; look for signs of deteriorating asset quality or significant shifts in deposit growth versus credit growth.|Quick check: HDFCBANK bearish bias (-2.6% 1d), ICICIBANK neutral (-0.6% 1d).
Given the specific company-centric negative news, traders should focus on RVNL (RVNL) with a bearish bias, looking for confirmation of downtrend continuation.|Quick check: RVNL bearish bias (oversold), SUNPHARMA neutral (-0.1% 1d).
Consider a defensive stance in equities; monitor bond yields for signs of sustained capital rotation.|Quick check: NIFTY neutral (-98.5% 1d), BANKNIFTY neutral.
For stocks undergoing OFS, consider a short-term bearish bias due to increased supply, but look for potential 'buy the dip' opportunities if technical indicators suggest oversold conditions.|Quick check: MARUTI neutral (oversold), TATAMOTORS bullish bias (+3.4% 1d).
Maintain a cautious but opportunistic bias in auto stocks; look for strong volume growth and positive commentary on demand, with strict risk discipline.|Quick check: KOTAKBANK bullish bias (-0.8% 1d), NIFTY neutral (-98.5% 1d).
Maintain a bullish bias on railway infrastructure and green hydrogen-focused companies; look for entry points on dips, with a focus on long-term growth potential.|Quick check: RELIANCE neutral (-0.7% 1d), ONGC bearish bias (+0.8% 1d).